retatrutide logo Premium 3ml Vial Labels for 15mg Retatrutide. The next evolution. A

Patients who need to start treatment immediately Those with type 2 diabetes (covered indication in most provinces) Patients who prefer a medication with longer real-world safety data Individuals whose insurance covers Ozempic but will not cover future medications Those who achieved satisfactory results on semaglutide previously Patients who can wait for optimal efficacy might consider holding for Retatrutide approval if their condition permits

GLP-1 receptor activation suppresses appetite and slows gastric emptying

15 Marciani L, Gowland PA, Spiller RC, Manoj P, Moore RJ, Young P, Al-Sahab S, Bush D, Wright J, Fillery-Travis AJ

Start Your Retatrutide Journey Today If youre looking for: A next-gen solution Safe, guided support Real, sustainable results Then Retatrutide may be your breakthrough